Financial updates - Myosin Therapeutics

Financial updates

Myosin Therapeutics Closes Second Seed Round to Advance Clinical Trials for Innovative Cancer and Neuroscience Therapies

JUPITER, Fla., Feb. 26, 2025 /PRNewswire/ — Myosin Therapeutics, Inc., a biotechnology company developing novel...

February 26, 2025

Financial updates

Myosin Therapeutics Successfully Transitions to Second Phase of NCI’s Fast Track Funding to Advance MT-125

Jupiter, FL – [January 16, 2024] – After milestone review by the NIH’s National Cancer...

January 16, 2024

Financial updates

Myosin Therapeutics Closes Seed Round to Continue Development of Innovative Therapies for Glioblastoma and Stimulant Use Disorder

Jupiter, FL – [March 7th, 2023] – Myosin Therapeutics Inc., a biotechnology company leveraging its...

March 07, 2023